Breaking News Instant updates and real-time market news.

BCPC

Balchem

$96.61

-0.81 (-0.83%)

04:55
06/12/19
06/12
04:55
06/12/19
04:55

Balchem management to meet with Sidoti

Meeting to be held in the Mid-Atlantic region on June 12 hosted by Sidoti.

  • 12

    Jun

  • 20

    Jun

  • 24

    Jul

BCPC Balchem
$96.61

-0.81 (-0.83%)

11/06/18
11/06/18
UPGRADE
Target $100

Buy
Balchem upgraded to Buy with $100 price target at Pivotal Research
As previously reported, Pivotal Research analyst Timothy Ramey upgraded Balchem to Buy from Hold, stating that he has "long admired" the company's excellent growth and now he sees the shares at an attractive entry point. The company's balance sheet "remains a powerhouse" and Ramey would not be surprised by another deal for the company, which he calls "masterful at the tuck-in accretive deal." Ramey raised his price target on Balchem shares to $100 on the heels of the company's Q3 earnings beat.
12/10/18
HCWC
12/10/18
NO CHANGE
Target $101
HCWC
Buy
Balchem price target lowered to $101 from $140 at H.C. Wainwright
H.C. Wainwright analyst Raghuram Selvaraju lowered his price target for Balchem to $101 to reflect "both challenges in maintaining top-line revenue growth as well as the substantial recent re-rating of sector comparable firms." The analyst, however, reiterates a Buy rating on the shares, "particularly considering the recent decline," which he believes ought to make the stock attractive again.
02/21/19
GHSC
02/21/19
INITIATION
GHSC
Neutral
Balchem initiated with a Neutral at Seaport Global
Seaport Global analyst Brett Hundley initiated Balchem with a Neutral rating citing difficult comps in 1H 2019 and a "robust" valuation.
05/06/19
PIVT
05/06/19
DOWNGRADE
Target $100
PIVT
Hold
Balchem downgraded to Hold from Buy at Pivotal Research
Pivotal Research analyst Timothy Ramey downgraded Balchem to Hold from Buy following what he called a "tough quarter with poor sales performance across the board." While he believes the company is well-managed, he notes that Balchem is exposed to higher input costs and Ramey views the shares as fairly valued given that he sees Q1 being the start of "a weak year." He maintains a $100 price target on Balchem shares.

TODAY'S FREE FLY STORIES

07:45
06/26/19
06/26
07:45
06/26/19
07:45
General news
U.S. MBA reported mortgage applications bounced 1.3% »

U.S. MBA reported…

UPWK

Upwork

$15.07

-0.41 (-2.65%)

, FVRR

Fiverr

$29.00

-0.2 (-0.68%)

07:44
06/26/19
06/26
07:44
06/26/19
07:44
Upgrade
Upwork, Fiverr rating change  »

Upwork upgraded to Buy…

UPWK

Upwork

$15.07

-0.41 (-2.65%)

FVRR

Fiverr

$29.00

-0.2 (-0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LINX

Linx S.A.

$0.00

(0.00%)

07:41
06/26/19
06/26
07:41
06/26/19
07:41
Syndicate
Linx S.A. 32.8M share IPO priced at $9.40 »

We are told the official…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

07:40
06/26/19
06/26
07:40
06/26/19
07:40
General news
Treasury Market Outlook: Treasury yields jumped higher »

Treasury Market Outlook:…

BBRX

Braeburn Pharmaceuticals

$0.00

(0.00%)

07:38
06/26/19
06/26
07:38
06/26/19
07:38
Initiation
Braeburn Pharmaceuticals initiated  »

Braeburn Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FISV

Fiserv

$90.27

-0.53 (-0.58%)

07:38
06/26/19
06/26
07:38
06/26/19
07:38
Upgrade
Fiserv rating change  »

Fiserv upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EVSI

Envision Solar

$5.11

-0.22 (-4.13%)

07:38
06/26/19
06/26
07:38
06/26/19
07:38
Initiation
Envision Solar initiated  »

Envision Solar initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KDMN

Kadmon

$1.66

-0.05 (-2.93%)

07:37
06/26/19
06/26
07:37
06/26/19
07:37
Initiation
Kadmon initiated  »

Oppenheimer bullish on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVCR

Novocure

$57.44

-0.58 (-1.00%)

07:37
06/26/19
06/26
07:37
06/26/19
07:37
Hot Stocks
Novocure announces publication of IQWiG rapid report for Optune »

Novocure announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSTR

CapStar Financial

$15.01

0.05 (0.33%)

07:37
06/26/19
06/26
07:37
06/26/19
07:37
Downgrade
CapStar Financial rating change  »

CapStar Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCRX

Pacira

$43.53

0.39 (0.90%)

07:35
06/26/19
06/26
07:35
06/26/19
07:35
Hot Stocks
Pacira says results show EXPAREL associated with 'significantly less' opioid use »

Pacira BioSciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ODT

Odonate Therapeutics

$28.14

-0.29 (-1.02%)

07:35
06/26/19
06/26
07:35
06/26/19
07:35
Syndicate
Odonate Therapeutics 4.75M share Spot Secondary priced at $26.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

  • 26

    Jun

X

U.S. Steel

$14.93

0.48 (3.32%)

07:35
06/26/19
06/26
07:35
06/26/19
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EGO

Eldorado Gold

$5.46

-0.02 (-0.36%)

07:34
06/26/19
06/26
07:34
06/26/19
07:34
Upgrade
Eldorado Gold rating change  »

Eldorado Gold upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XON

Intrexon

$7.34

0.17 (2.37%)

07:33
06/26/19
06/26
07:33
06/26/19
07:33
Hot Stocks
Intrexon doses first patient in Phase 1/1b study of Acute Myeloid Leukemia drug »

Intrexon's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BOSC

B.O.S. Better Online

$2.73

(0.00%)

07:33
06/26/19
06/26
07:33
06/26/19
07:33
Hot Stocks
B.O.S. Better Online receives $870,000 order for robotic system »

B.O.S Better Online…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRIM

Primoris

$19.57

0.32 (1.66%)

07:32
06/26/19
06/26
07:32
06/26/19
07:32
Hot Stocks
Primoris announces heavy civil award valued over $24M »

Primoris Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSFT

Microsoft

$133.43

-4.37 (-3.17%)

, AMZN

Amazon.com

$1,879.26

-34.17 (-1.79%)

07:31
06/26/19
06/26
07:31
06/26/19
07:31
Recommendations
Microsoft, Amazon.com, Oracle analyst commentary at Wedbush »

Pentagon JEDI contract to…

MSFT

Microsoft

$133.43

-4.37 (-3.17%)

AMZN

Amazon.com

$1,879.26

-34.17 (-1.79%)

ORCL

Oracle

$56.07

-0.65 (-1.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

  • 10

    Jul

  • 06

    Aug

EXTR

Extreme Networks

$5.73

0.08 (1.42%)

07:30
06/26/19
06/26
07:30
06/26/19
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

DNLI

Denali Therapeutics

$20.22

0.56 (2.85%)

07:29
06/26/19
06/26
07:29
06/26/19
07:29
Initiation
Denali Therapeutics initiated  »

Denali Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRCM

Care.com

$14.13

0.21 (1.51%)

07:28
06/26/19
06/26
07:28
06/26/19
07:28
Recommendations
Care.com analyst commentary  »

Care.com CFO resignation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRCM

Care.com

$14.13

0.21 (1.51%)

07:28
06/26/19
06/26
07:28
06/26/19
07:28
Downgrade
Care.com rating change  »

Care.com downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LEN

Lennar

$48.24

-3.17 (-6.17%)

07:27
06/26/19
06/26
07:27
06/26/19
07:27
Recommendations
Lennar analyst commentary  »

Lennar selloff appears…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 28

    Jun

MU

Micron

$32.71

-0.47 (-1.42%)

07:27
06/26/19
06/26
07:27
06/26/19
07:27
Upgrade
Micron rating change  »

Micron upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

AVAV

AeroVironment

07:27
06/26/19
06/26
07:27
06/26/19
07:27
Recommendations
AeroVironment analyst commentary  »

AeroVironment price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.